Discovery of novel antibiotics

Product or Service High throughput screening and lead discovery

A large network of 17 experienced screening centres, including two institutes with focus on infectious diseases.

  • Antimicrobial compound/strategy

  • Bacteria
  • Viruses
  • Fungi
  • Parasites

  • Human
  • Veterinary
  • AgriFood

Development stage:
  • Research
  • Development

  • Academia

  • License, Co-develop, Joint Venture

Funding organisation:
  • OTHER / NA

Infectious disease area:
  • UTI
  • STI
  • BSI
  • RTI
  • GII
  • SSTI
  • CNSI
  • IAI
  • SSI

Geographic origin:
  • Eurasia

Embargo period of up to three years before screening data become open access. EU-OPENSCREEN works with full cost model and claims no IPR.

European research infrastructure consortium (ERIC) for chemical biology

Access to commercial and proprietary compound collections, medicinal chemistry expertise at 6 sites. Co-development of novel screening technologies.

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!